Cost-effectiveness analysis of first-line gifitinib plus pemetrexed-platinum-based chemotherapy versus gifitinib monotherapy in EGFR-mutated NSCLC patients with brain metastases

Related articles

1. A Study on the Efficacy of Immune Checkpoint Inhibitors Combined with Chemotherapy in Patients with Oligometastatic Driver Gene-Negative Non-Small Cell Lung Cancer Undergoing Radiotherapy

   This article has 10 authors:

   1. Yang Liu
   2. Lingxiao Xie
   3. Jiaoyue Qu
   4. Quan Pan
   5. Zhao Yu
   6. Yin Yuan
   7. Chunyu Chang
   8. Hao Jiang
   9. Yuexin Yang
   10. Gengming Wang at

2. Efficacy and safety of different PD-1 inhibitors as first-line treatment for advanced or metastatic squamous non-small cell lung cancer: A retrospective real-world study

   This article has 4 authors:

   1. Mengjiao Fu
   2. Jingjing Qu
   3. Jianya Zhou
   4. Jianying Zhou

3. Real-World Effectiveness of Cisplatin, 5-Fluorouracil, and Pembrolizumab Combination Therapy for Unresectable or Recurrent Esophageal Cancer

   This article has 9 authors:

   1. Yu Ueta
   2. Masanobu Nakajima
   3. Masaki Yoshimatsu
   4. Takahiro Ochiai
   5. Shuhei Takise
   6. Junki Fujita
   7. Masatoshi Nakagawa
   8. Shinji Morita
   9. Kazuyuki Kojima